Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer.
暂无分享,去创建一个
N. Pryer | T. Abrams | Leslie B. Lee | Lesley J. Murray | J. Cherrington | E. Pesenti | T. Colombo | Vicky Walker Holway